Your session is about to expire
← Back to Search
Postnatal Multivitamins for Healthy Nutrition During Breastfeeding
N/A
Recruiting
Research Sponsored by City University of New York
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up after 10 weeks of intervention
Awards & highlights
Study Summary
This trial will investigate if taking a prenatal multivitamin can improve nutrition for moms and babies who are exclusively breastfeeding at week 5 postpartum.
Who is the study for?
This trial is for postpartum women over 18 years old who are exclusively breastfeeding and plan to continue for at least 10 more weeks. It's not suitable for those with cardiovascular conditions, diabetes, or liver disease prior to or during pregnancy.Check my eligibility
What is being tested?
The study tests if taking Ritual Epre Multimineral-Vitamin Supplement improves nutrition in mothers and babies during lactation compared to a placebo. Participants will be randomly assigned to either the supplement group or placebo group in this double-blind trial.See study design
What are the potential side effects?
Since the intervention involves multivitamins that are generally considered safe, side effects might be minimal but could include mild digestive discomfort or allergic reactions.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ after 10 weeks of intervention
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~after 10 weeks of intervention
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Breastmilk MK-7 content
Breastmilk biotin content
Breastmilk folate content
+7 moreTrial Design
2Treatment groups
Experimental Treatment
Placebo Group
Group I: Ritual EpreExperimental Treatment1 Intervention
This group will receive 2 Ritual Epre multivitamin-mineral supplement pills daily.
Group II: ControlPlacebo Group1 Intervention
This group will receive a blank placebo.
Find a Location
Who is running the clinical trial?
City University of New YorkLead Sponsor
17 Previous Clinical Trials
5,583 Total Patients Enrolled
Maimonides Medical CenterOTHER
69 Previous Clinical Trials
15,225 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have had heart conditions before and during my pregnancy.I am a woman over 10 years old and pregnant with one baby.I have had diabetes before and during my pregnancy.I have had liver disease before and during my pregnancy.
Research Study Groups:
This trial has the following groups:- Group 1: Ritual Epre
- Group 2: Control
Awards:
This trial has 0 awards, including:Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Is this clinical study still accepting participants?
"Clinicaltrials.gov indicates that this medical trial, which was initially advertised on March 1st 2023 and revised on February 8th of the same year is no longer actively recruiting patients. Fortunately, there are 27 other studies that require volunteers at this time."
Answered by AI
Share this study with friends
Copy Link
Messenger